When to treat, delay, or omit breast cancer therapy in the face of COVID-19April 10, 2020Breast CancerOncology
Home-based chemo skyrockets at one U.S. centerApril 10, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Managing pediatric heme/onc departments during the pandemicApril 9, 2020Lymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, TransplantationOncology
First report of MM patient successfully treated for COVID-19 with tocilizumabApril 6, 2020Multiple MyelomaOncology
Advice from the front lines: How cancer centers can cope with COVID-19April 2, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
20% with cancer on checkpoint inhibitors get thyroid dysfunctionApril 2, 2020OncologyBreast CancerLung CancerLymphoma & Plasma Cell Disorders
Maintaining cancer care in the face of COVID-19April 1, 2020Genitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersLung CancerMultiple MyelomaMelanoma
Barriers to clinical trial participation revealed by gynecologic cancer patientsMarch 31, 2020Oncology
Blood test might detect multiple cancer types, study suggestsMarch 31, 2020OncologyMixed TopicsLung CancerHematologyHead & Neck/Thyroid CancersLymphoma & Plasma Cell DisordersGenitourinary Cancer
